ACTRN12614000172606已完成未知
What are the determinants of under vaccination rates of infants and children in Western Australia
Telethon Institute for Child Health Research0 个研究点目标入组 1,000 人开始时间: 2014年2月12日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 16 Years 至 o limit（—）
- 性别
- All
入选标准
- •Parents / Guardians of children under 6 years of age giving informed consent
排除标准
- •Previously enrolled
研究者
相似试验
已完成
不适用
Factors influencing the decision to vaccinate against Covid-19 and seasonal influenza in adults with and without depression/anxiety in primary careanxiety disorderbronchial asthma, COPD, type 1/2 diabetes mellitus, coronary artery disease or breast cancerdepressionDRKS00030042Friedrich-Baur-Stiftung, LMU Klinikum803
进行中（未招募）
1 期
Exploring novel mechanisms of vaccine failure and induction of pulmonary immunity following live attenuated influenza vaccination in HIV infected and uninfected individuals: a pilot study.HIV (effect of HIV on the response to live attenuated intranasal influenza vaccine)MedDRA version: 20.1 Level: LLT Classification code 10020160 Term: HIV disease System Organ Class: 100000004862EUCTR2014-001924-31-GBSheffield Teaching Hospitals NHS Foundation Trust30
尚未招募
Unknown
A study on infections which can be prevented with vaccines among adults in a tertiary care hospital.CTRI/2024/06/068812Dr Nivedha R b
进行中（未招募）
不适用
A study of the immune response to vaccination in MS patients treated with alemtuzumab - CAM-VACThe vaccinations are being used to investigate immunological memory following treatment of multiple sclerosis with the lympho-depleting humanised monoclonal antibody alemtuzumab.MedDRA version: 9.1Level: PTClassification code 10063399Term: Relapsing-remitting multiple sclerosisMedDRA version: 9.1Level: PTClassification code 10063400Term: Secondary progressive multiple sclerosisMedDRA version: 9.1Level: LLTClassification code 10046859Term: VaccinationEUCTR2009-011523-31-GBR & D, Cambridge University Hospitals60
已完成
不适用
Immune response to oral vaccinesCTRI/2012/10/003057Centre for Health Research and Development Society for Applied Studies400